Luminex Buys Nanosphere, Citing Infectious Disease Dx Strengths
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics firm Luminex will add Nanosphere's Verigene bloodstream-infection testing platform and its molecular microbiology strength to broaden its reach in the lab market.